Tag:
THE LIBRARY: WEBINAR
Getting the most PoC data in Phase I cancer studies
The hunt for proof-of-concept data is steadily moving upstream in the clinic. Join FierceBiotech on June 12th as three clinical trial experts tackle the question of how you can best design a Phase I study to get a readout on efficacy. Topics will include: enrollment, dosing and the best possible use of biomarkers for experimental cancer drugs. Register Today!
EVENTS
- Clinical Trials Eastern Europe Webinar SeriesMay 15-June 12 — Eastern Europe
- Don't miss an Exclusive Executive Breakfast at BIO 2012!June 19, 2012 — Boston, MA
Press Releases
- Intermountain Healthcare and Myriad Genetics Enter Into Research Collaboration Agreement
- AVEO Initiates Phase 1 Study of AV-203, an ERBB3 Inhibitory Antibody, in Advanced Solid Tumors
- Halo Therapeutics Raises $1.1 Million to Expedite Phase 2 Study of HT-100
- InterMune to Divest Actimmune® (Interferon Gamma-1b)
- France Biotech presents the results of its tenth annual "Life Science Panorama 2011" survey, conducted in partnership with Ernst & Young
- More Press Releases
Featured Jobs
-
Sr. IT Infrastructure Architect Job
Celgene Corporation - Berkeley Heights, NJ, US -
Oncology Knowledge Lead
Merck - Boston, MA -
Biostatistician (Entry Level) - Permanent Job
Yoh - Tarrytown, NY, USA -
Director, Human Resources
TESARO - Waltham, MA -
Statistician Job
Yoh - Montville, NJ, USA
